During the National Comprehensive Cancer Network (NCCN) 2021 Annual Conference, the Mutiple Myeloma Hub spoke to Timothy M. Schmidt, University of Wisconsin-Madison, Madison, US. We asked about updates to the NCCN guidelines for the diagnosis and treatment of monoclonal gammopathy of unknown significance (MGUS) and smoldering multiple myeloma (SMM).